Compile Data Set for Download or QSAR
Report error Found 516 Enz. Inhib. hit(s) with all data for entry = 11121
TargetHistone deacetylase 1(Human)
The General Hospital

US Patent
LigandPNGBDBM592497(US11572368, Compound 186)
Affinity DataIC50: 50nMAssay Description:HDAC1: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. Trypsin Coupled...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
The General Hospital

US Patent
LigandPNGBDBM592496(US11572368, Compound 185)
Affinity DataIC50: 50nMAssay Description:HDAC2: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. HDAC2-Kinetic I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
The General Hospital

US Patent
LigandPNGBDBM592496(US11572368, Compound 185)
Affinity DataIC50: 50nMAssay Description:HDAC1: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. Trypsin Coupled...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
The General Hospital

US Patent
LigandPNGBDBM592498(US11572368, Compound 187)
Affinity DataIC50: 50nMAssay Description:HDAC2: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. HDAC2-Kinetic I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
The General Hospital

US Patent
LigandPNGBDBM592498(US11572368, Compound 187)
Affinity DataIC50: 50nMAssay Description:HDAC1: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. Trypsin Coupled...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
The General Hospital

US Patent
LigandPNGBDBM592412(US11572368, Compound 25)
Affinity DataIC50: 50nMAssay Description:HDAC2: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. HDAC2-Kinetic I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
The General Hospital

US Patent
LigandPNGBDBM592412(US11572368, Compound 25)
Affinity DataIC50: 50nMAssay Description:HDAC1: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. Trypsin Coupled...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
The General Hospital

US Patent
LigandPNGBDBM592497(US11572368, Compound 186)
Affinity DataIC50: 50nMAssay Description:HDAC2: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. HDAC2-Kinetic I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
The General Hospital

US Patent
LigandPNGBDBM592413(US11572368, Compound 67)
Affinity DataIC50: 50nMAssay Description:HDAC2: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. HDAC2-Kinetic I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
The General Hospital

US Patent
LigandPNGBDBM592406(US11572368, Compound 18)
Affinity DataIC50: 50nMAssay Description:HDAC2: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. HDAC2-Kinetic I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
The General Hospital

US Patent
LigandPNGBDBM592406(US11572368, Compound 18)
Affinity DataIC50: 50nMAssay Description:HDAC1: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. Trypsin Coupled...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
The General Hospital

US Patent
LigandPNGBDBM592491(US11572368, Compound 172)
Affinity DataIC50: 50nMAssay Description:HDAC2: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. HDAC2-Kinetic I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
The General Hospital

US Patent
LigandPNGBDBM592491(US11572368, Compound 172)
Affinity DataIC50: 50nMAssay Description:HDAC1: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. Trypsin Coupled...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
The General Hospital

US Patent
LigandPNGBDBM50189903(CHEMBL3828396 | US11572368, Compound 54)
Affinity DataIC50: 50nMAssay Description:HDAC2: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. HDAC2-Kinetic I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
The General Hospital

US Patent
LigandPNGBDBM592407(US11572368, Compound 86)
Affinity DataIC50: 50nMAssay Description:HDAC2: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. HDAC2-Kinetic I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
The General Hospital

US Patent
LigandPNGBDBM592409(US11572368, Compound 87)
Affinity DataIC50: 50nMAssay Description:HDAC1: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. Trypsin Coupled...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
The General Hospital

US Patent
LigandPNGBDBM592410(US11572368, Compound 88)
Affinity DataIC50: 50nMAssay Description:HDAC2: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. HDAC2-Kinetic I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
The General Hospital

US Patent
LigandPNGBDBM592409(US11572368, Compound 87)
Affinity DataIC50: 50nMAssay Description:HDAC2: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. HDAC2-Kinetic I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
The General Hospital

US Patent
LigandPNGBDBM592422(US11572368, Compound 106)
Affinity DataIC50: 50nMAssay Description:HDAC2: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. HDAC2-Kinetic I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
The General Hospital

US Patent
LigandPNGBDBM592422(US11572368, Compound 106)
Affinity DataIC50: 50nMAssay Description:HDAC1: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. Trypsin Coupled...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
The General Hospital

US Patent
LigandPNGBDBM592423(US11572368, Compound 124)
Affinity DataIC50: 50nMAssay Description:HDAC2: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. HDAC2-Kinetic I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
The General Hospital

US Patent
LigandPNGBDBM592423(US11572368, Compound 124)
Affinity DataIC50: 50nMAssay Description:HDAC1: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. Trypsin Coupled...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
The General Hospital

US Patent
LigandPNGBDBM592425(US11572368, Compound 129)
Affinity DataIC50: 50nMAssay Description:HDAC1: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. Trypsin Coupled...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
The General Hospital

US Patent
LigandPNGBDBM592424(US11572368, Compound 128)
Affinity DataIC50: 50nMAssay Description:HDAC2: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. HDAC2-Kinetic I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
The General Hospital

US Patent
LigandPNGBDBM592424(US11572368, Compound 128)
Affinity DataIC50: 50nMAssay Description:HDAC1: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. Trypsin Coupled...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
The General Hospital

US Patent
LigandPNGBDBM592425(US11572368, Compound 129)
Affinity DataIC50: 50nMAssay Description:HDAC2: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. HDAC2-Kinetic I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
The General Hospital

US Patent
LigandPNGBDBM592419(US11572368, Compound 56)
Affinity DataIC50: 50nMAssay Description:HDAC2: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. HDAC2-Kinetic I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
The General Hospital

US Patent
LigandPNGBDBM592419(US11572368, Compound 56)
Affinity DataIC50: 50nMAssay Description:HDAC1: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. Trypsin Coupled...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
The General Hospital

US Patent
LigandPNGBDBM592420(US11572368, Compound 96)
Affinity DataIC50: 50nMAssay Description:HDAC1: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. Trypsin Coupled...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
The General Hospital

US Patent
LigandPNGBDBM592433(US11572368, Compound 113)
Affinity DataIC50: 50nMAssay Description:HDAC1: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. Trypsin Coupled...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
The General Hospital

US Patent
LigandPNGBDBM592350(US11572368, Compound 16)
Affinity DataIC50: 50nMAssay Description:HDAC1: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. Trypsin Coupled...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
The General Hospital

US Patent
LigandPNGBDBM592434(US11572368, Compound 115)
Affinity DataIC50: 50nMAssay Description:HDAC2: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. HDAC2-Kinetic I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
The General Hospital

US Patent
LigandPNGBDBM592434(US11572368, Compound 115)
Affinity DataIC50: 50nMAssay Description:HDAC1: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. Trypsin Coupled...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
The General Hospital

US Patent
LigandPNGBDBM592433(US11572368, Compound 113)
Affinity DataIC50: 50nMAssay Description:HDAC2: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. HDAC2-Kinetic I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
The General Hospital

US Patent
LigandPNGBDBM592351(US11572368, Compound 13)
Affinity DataIC50: 50nMAssay Description:HDAC2: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. HDAC2-Kinetic I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
The General Hospital

US Patent
LigandPNGBDBM592351(US11572368, Compound 13)
Affinity DataIC50: 50nMAssay Description:HDAC1: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. Trypsin Coupled...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
The General Hospital

US Patent
LigandPNGBDBM592350(US11572368, Compound 16)
Affinity DataIC50: 50nMAssay Description:HDAC2: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. HDAC2-Kinetic I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
The General Hospital

US Patent
LigandPNGBDBM592343(US11572368, Compound 4)
Affinity DataIC50: 50nMAssay Description:HDAC2: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. HDAC2-Kinetic I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
The General Hospital

US Patent
LigandPNGBDBM592343(US11572368, Compound 4)
Affinity DataIC50: 50nMAssay Description:HDAC1: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. Trypsin Coupled...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
The General Hospital

US Patent
LigandPNGBDBM592427(US11572368, Compound 98)
Affinity DataIC50: 50nMAssay Description:HDAC2: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. HDAC2-Kinetic I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
The General Hospital

US Patent
LigandPNGBDBM592427(US11572368, Compound 98)
Affinity DataIC50: 50nMAssay Description:HDAC1: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. Trypsin Coupled...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
The General Hospital

US Patent
LigandPNGBDBM592429(US11572368, Compound 114)
Affinity DataIC50: 50nMAssay Description:HDAC1: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. Trypsin Coupled...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
The General Hospital

US Patent
LigandPNGBDBM592428(US11572368, Compound 133)
Affinity DataIC50: 50nMAssay Description:HDAC2: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. HDAC2-Kinetic I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
The General Hospital

US Patent
LigandPNGBDBM592428(US11572368, Compound 133)
Affinity DataIC50: 50nMAssay Description:HDAC1: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. Trypsin Coupled...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
The General Hospital

US Patent
LigandPNGBDBM592345(US11572368, Compound 30)
Affinity DataIC50: 50nMAssay Description:HDAC2: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. HDAC2-Kinetic I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
The General Hospital

US Patent
LigandPNGBDBM592345(US11572368, Compound 30)
Affinity DataIC50: 50nMAssay Description:HDAC1: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. Trypsin Coupled...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
The General Hospital

US Patent
LigandPNGBDBM592429(US11572368, Compound 114)
Affinity DataIC50: 50nMAssay Description:HDAC2: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. HDAC2-Kinetic I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
The General Hospital

US Patent
LigandPNGBDBM592431(US11572368, Compound 92)
Affinity DataIC50: 50nMAssay Description:HDAC2: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. HDAC2-Kinetic I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
The General Hospital

US Patent
LigandPNGBDBM592431(US11572368, Compound 92)
Affinity DataIC50: 50nMAssay Description:HDAC1: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. Trypsin Coupled...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
The General Hospital

US Patent
LigandPNGBDBM592443(US11572368, Compound 94)
Affinity DataIC50: 50nMAssay Description:HDAC1: The following trypsin-coupled protocol and Caliper protocol described Herein was used to assay the compounds of the invention. Trypsin Coupled...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2023
Entry Details
US Patent

Displayed 1 to 50 (of 516 total ) | Next | Last >>
Jump to: